XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Reconciliation of Common Stock Outstanding
The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2023 and the twelve months ended December 31, 2022:
NINE MONTHS ENDED SEPTEMBER 30, 2023TWELVE MONTHS ENDED DECEMBER 31, 2022
Balance, beginning of period380,589,894 150,457,433 
Issuance of common stock7,397 229,618,304 
Non-vested share-based awards, net of withheld shares 262,821 514,157 
Balance, end of period380,860,112 380,589,894 
Schedule of Earnings (Loss) per Share
The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2023 and 2022.
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
Dollars in thousands, except per share data2023202220232022
Weighted average common shares outstanding
Weighted average common shares outstanding380,857,560 330,788,997 380,828,004 211,740,767 
Non-vested shares(1,932,221)(1,983,742)(1,941,897)(1,933,957)
Weighted average common shares outstanding - basic378,925,339 328,805,255 378,886,107 209,806,810 
Weighted average common shares outstanding - basic378,925,339 328,805,255 378,886,107 209,806,810 
Dilutive effect of forward equity shares— — — — 
Dilutive effect of OP Units— 3,167,668 — 1,067,493 
Dilutive effect of employee stock purchase plan— 58,461 — 69,687 
Weighted average common shares outstanding - diluted378,925,339 332,031,384 378,886,107 210,943,990 
Net (loss) income$(68,604)$28,616 $(240,408)$76,973 
Income allocated to participating securities(636)(610)(1,868)(1,817)
Loss (income) attributable to non-controlling interest760 (312)2,680 (312)
Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units(29)— (122)— 
Net (loss) income applicable to common stockholders - basic$(68,509)$27,694 $(239,718)$74,844 
Basic earnings per common share - net income$(0.18)$0.08 $(0.63)$0.36 
Diluted earnings per common share - net income$(0.18)$0.08 $(0.63)$0.35 
Summary of the Activity Under the Incentive Plan and RSU Activity
A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September 30, 2023 and 2022 is included in the table below.
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
 2023202220232022
Share-based awards, beginning of period1,932,221 1,941,709 1,795,128 1,562,028 
Granted— 71,852 313,770 513,876 
Vested— (7,434)(152,314)(68,481)
Forfeited— (4,130)(24,363)(5,426)
Share-based awards, end of period1,932,221 2,001,997 1,932,221 2,001,997 
The following is a summary of the RSU activity during the three and nine months ended September 30, 2023:
THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30,
 Restricted Stock UnitsWeighted Average Grant Date Fair ValueRestricted Stock UnitsWeighted Average Grant Date Fair Value
Non-vested, beginning of period363,250 $28.57 294,932 $33.04 
Granted— — 165,174 22.55 
Vested/Forfeited— — (17,606)33.04 
Probability adjustment of 2022 & 2023 RSUs (47,196)20.21 (126,446)27.40 
Non-vested, end of period316,054 $27.77 316,054 $27.77 
Schedule of Stock Options, Valuation Assumptions
THREE MONTHS ENDED MARCH 31,
Volatility34.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
THREE MONTHS ENDED MARCH 31,
Volatility34.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
Summary of Employee Stock Purchase Plan Activity A summary of the activity under the ESPP for the three and nine months ended September 30, 2023 and 2022 is included in the table below.
THREE MONTHS ENDED SEPTEMBER 30,NINE MONTHS ENDED SEPTEMBER 30,
 2023202220232022
Outstanding and exercisable, beginning of period179,369 405,534 340,976 348,514 
Granted— — — 255,960 
Exercised(2,580)(4,576)(7,397)(17,094)
Forfeited(4,680)(37,628)(28,471)(83,417)
Expired— — (132,999)(140,633)
Outstanding and exercisable, end of period172,109 363,330 172,109 363,330 
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The following table represents expected amortization of the Company's non-vested shares issued as of September 30, 2023:
Dollars in millionsFUTURE AMORTIZATION
of non-vested shares
2023$4.1 
202413.3 
202510.8 
20268.0 
20272.4 
2028 and thereafter0.5 
Total$39.1